Biofrontera Inc. WOBURN, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that PM360, a publication for marketing decision makers in the pharmaceutical, biotech, diagnostics and medical device industries, has awarded the previously nominated Ameluz® marketing […]

Mandiant has identified an ongoing information operations (IO) campaign leveraging a network of at least 72 suspected inauthentic news sites and a number of suspected inauthentic social media assets to disseminate content strategically aligned with the political interests of the People’s Republic of China (PRC). The sites present themselves primarily […]